< 1 minute read
Sep. 17, 2021
CPI-1612: An EP300/CBP histone acetyltransferase (HAT) inhibitor tool compound
CPI-1612
bioavailable EP300/CBP HAT inhibitor brain penetrant, orally efficacious in xeno. from HTS and SBDD ACS Med. Chem. Lett., Apr. 27, 2020 Constellation Pharma., Cambridge, MA
Loading...
